Ledger.Open graph →
SEC Form D · filed November 24, 2025

Pelage Pharmaceuticals, Inc

Offering
$120.0M
Sold
$120.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Cathy E. Friedman · Los Angeles, CADirectorWilliam E. Lowry · Los Angeles, CAExec · DirectorDaniel Gil · Los Angeles, CAExec · DirectorJim B. Graham · Austin, TXExec · DirectorIsaac D. Barchas · Austin, TXExec · DirectorSara Lewis · Brooklyn, NYDirectorNathan E. Wheeler · Los Angeles, CAExecChristina E. Weng · Los Angeles, CAExecRichard E. Heyman · Los Angeles, CADirectorJeremy J. Coller · St Peter Port, Y7Exec · DirectorRoger A. Le Tissier · St Peter Port, Y7Exec · DirectorPeter Sheppeard · Toronto, Ontario, CanadaDirectorNathan E. Wheeler · Los Angeles, CAExecChristina E. Weng · Los Angeles, CAExecRichard E. Heyman · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗